T cell targeted strategies for improved efficacy and safety of specific immunotherapy for allergic disease
{{output}}
Allergic diseases including asthma, rhinitis and eczema are known to be a major health and economic burden worldwide. Specific immunotherapy (SIT) is potentially curative but restricted in use, e.g. for asthmatics, due to risk of serious adverse events. Safer,... ...
